Silvercrest Asset Management’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4M Buy
36,457
+5,379
+17% +$766K 0.03% 455
2025
Q4
$5.17M Buy
31,078
+11,906
+62% +$1.99M 0.04% 428
2025
Q3
$3.75M Sell
19,172
-11,922
-38% -$1.96M 0.02% 464
2025
Q2
$2.81M Sell
31,094
-1,031
-3% -$81.5K 0.02% 505
2025
Q1
$1.92M Sell
32,125
-760
-2% -$70.3K 0.01% 548
2024
Q4
$4.36M Sell
32,885
-564
-2% -$52.9K 0.03% 440
2024
Q3
$1.75M Buy
+33,449
New +$1.57M 0.01% 511

Other funds holding ALAB

Silvercrest Asset Management's ALAB Position: Q1 2026 in Review

Silvercrest Asset Management increased its Astera Labs (ALAB) stake by 17% in Q1 2026, buying an estimated $766K and bringing the position to 36,457 shares worth $4M. The position accounts for 0.03% of the portfolio, ranked #455.

Silvercrest Asset Management first reported a position in ALAB in Q3 2024 and has held it in 7 quarters since. The position peaked at $5.17M in Q4 2025. 703 funds tracked by Wall St. Rank hold ALAB as of Q1 2026.

  • Silvercrest Asset Management held 36,457 shares of Astera Labs worth $4M as of Q1 2026.
  • Silvercrest Asset Management bought 5,379 Astera Labs shares in Q1 2026, an estimated $766K.
  • Astera Labs made up 0.03% of Silvercrest Asset Management's portfolio in Q1 2026, its #455 holding.
  • Silvercrest Asset Management first reported a position in Astera Labs in Q3 2024 and has held it in 7 quarters since.
  • Silvercrest Asset Management's Astera Labs position peaked at $5.17M in Q4 2025.
  • 703 funds tracked by Wall St. Rank held Astera Labs as of Q1 2026.

Based on Silvercrest Asset Management's 13F filing for Q1 2026, filed 15 May 2026.